美国和西欧的白内障治疗药市场(2023年):2022年～2028年的各地区分析

本报告提供美国和西欧的白内障治疗药市场相关调查，市场概要，以及今后5年的市场效能预测，平均销售价格，未来趋势等资讯。

目录

• 白内障的罹患率与白内障手术相关资讯
• 美国和西欧白内障手术数量预测(5年预测)
• 晶体存在式人工水晶体和屈光矫正镜头的替换方法相关的考察
• 白内障手术使用的抗生素的销售额预测
• 白内障手术使用的散瞳剂和睫状肌调节剂的销售额预测
• 白内障手术使用的抗发炎剂，止痛药的销售额预测
• 美国和西欧白内障及白内障/屈光矫正手术的外科医生的简介
• 企业的手术供应商相关资讯
• 目前偿付水准相关的讨论
• 开发中的新关于此产品的说明

What's New:

The second-edition "2023 US and Western Europe Cataract Pharmaceuticals Market Report" features new survey data and forecasts for the United States and Western European markets for cataract pharmaceuticals. The new data explore surgeon preferences for preventing infection, dilation, and managing inflammation and pain. The report now provides the market shares of leading competitors, analyzes pharmaceutical use in the United States by providers' surgical volume, and studies the developmental pipeline for drugs and drug delivery.

The "2023 US and Western Europe Cataract Pharmaceuticals Market Report" offers an in-depth examination of the current cataract pharmaceuticals market in the United States and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.

This comprehensive report covers the United States and Western European markets and provides:

• Information on cataract incidence and cataract surgeries.

• Current estimates and five-year forecasts for cataract surgery volumes in the United States and Western Europe.

• Discussion of phakic and refractive lens exchange procedures.

• Forecasts for sales of antibiotics used in association with cataract surgery.

• Forecasts for sales of mydriatics and cycloplegics used in cataract surgery.

• Forecasts for sales of anti-inflammatory drugs and painkillers used in association with cataract surgery.

• Profile of cataract and cataract/refractive surgeons in the United States and Western Europe

• Information on corporate surgery providers.

• Discussion of current reimbursement levels.

• Descriptions of new products in development.

Author Profile:

Peter Downs

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.